In a steady drumbeat of US sanctions targeting Iran during the month of November 2018, the Office of Foreign Assets Control has designated Iran-based financial facilitators of malicious cyber activity and, for the first time, associated digital currency addresses.
Last week, the United States District Court for the District of Delaware (the “Court”) reversed a 2015 decision by the Delaware Bankruptcy Court (the “Bankruptcy Court”) disallowing the portion of an unsecured claim filed by appellant Wilmington Trust Company (“WTC”) for postpetition attorneys’ fees
The jurisdictional skirmish over the regulation of cell-cultured meat products appears to have been resolved with the recent announcement by the FDA and the US Department of Agriculture of a joint regulatory framework in which the two agencies would share jurisdictional responsibilities.
Indenture trustees and agents participate in the administration of chapter 11 cases in a number of ways, including by protecting holders’ rights, ensuring compliance with the applicable indenture and other agreements, and fulfilling their duties and responsibilities under applicable law.
With only two months until the January 1 implementation of the final State Cannabis Regulations, the California agencies given licensing authority under the Medicinal and Adult-use Cannabis Regulation and Safety Act posted last minute changes that are causing quite a buzz in the cannabis community.
The FDA has delayed the date on which it plans to enforce compliance with certain Unique Device Identification (UDI) requirements, prompting a concerted sigh of relief throughout the medical device community.
Late last month, in Daniels v. Fan Duel, Inc., et ano, the Indiana Supreme Court sided with the fantasy sports industry holding that the use of the names, pictures, and statistics of athletes by online-fantasy sports operators without the athletes’ consent does not violate the right of publicity.
As the dust settles on a campaign cycle that was unprecedented in many ways, we have composed this biennial post-election analysis to assist our clients in assessing the potential impact of the elections on their organizations and their industries.
Colorado’s new consumer data protection law, the Protections for Consumer Data Privacy Act, took effect September 1 and companies now have another set of requirements to comply with for their data privacy compliance.
The Food and Drug Administration is maintaining its August 2017 commitment to step up enforcement against violative stem cell therapy and regenerative medicine companies. But FDA’s activity hasn’t stopped the Federal Trade Commission from flexing its own regulatory muscle against the same industry.
If the turbulence of 2018 caused business executives grief, the year ahead is unlikely to provide much relief. Foremost is the United States-Mexico-Canada Agreement (USMCA). If most political pundits are correct, the three governments will likely be able to ratify the USMCA in time to be in full fo
On October 11, the United States Patent and Trademark Office published a new final rule altering the claim construction standard applied in inter partes review, post grant review, and covered business method review proceedings.
Efforts to update FDA’s personal care products regulations continue as Rep. Jan Schakowsky (D-IL) recently introduced H.R. 6903, the “Safe Cosmetics and Personal Care Products Act of 2018.”
At Arent Fox, opportunity is a function of creativity, drive, and talent. You won’t find a top-down management structure setting the tone at our firm. Because we’re not a corporation, we’re a partnership. You’re in the driver’s seat. Let’s go.